CRMD - CorMedix Inc.

Day 1m 10m 60m PreMarket Market AfterHours Gap
10.73 -0.1 (-0.93%) --- --- --- -0.15 (-1.4%) 0.06 (0.57%) --- -0.15 (-1.4%)

Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: AfterHours

Earnings & Ratios

Basic EPS:
0.29
Diluted EPS:
0.28
Basic P/E:
36.6552
Diluted P/E:
37.9643
RSI(14) 1m:
31.12
VWAP:
10.61
RVol:
0.6165

Events

Period Kind Movement Occurred At
1m Price increase 1m 10.88 +0.19 (+1.78%) Oct 15 09:45
1m Price decrease 1m 10.57 -0.18 (-1.67%) Oct 15 07:22

Related News